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European Heart Journal ( 2014 ) 35 ( Abstract Supplement ), 1062
Background: Heart failure (HF) poses a unique medical burden of high morbidity and
mortality. Elevated resting heart rate is associated with worse outcomes in chronic HF but
little is known about its prognostic impact in acute setting.
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Methods and results: We examined the association of heart rate with in-hospital
mortality in a cohort of 778 patients admitted for acute HF between January 2010 and
December 2012. None of the patients had significant arrhythmias, required invasive
ventilation, or presented with acute coronary syndrome or primary valvular disease.
Heart rates was obtained 24-36 hours after admission. Forty patients died during the
hospital stay. Those patients were older (78±9 vs. 72±12 years; p=0.0021), had higher
heart rate (92±22 vs. 78±18 bpm; p<0.0001), NT pro-BNP (p=0.0005), creatinine (18±18
vs. 14±10 mg/dL; p=0.023), were often diabetics (p=0.026) and had lower systolic and
diastolic blood pressures (p<0.05). With multivariable analysis, age (p=0.008), heart rate
(p<0.0001), and creatinine (p=0.024) emerged as independent predictors of in-hospital
mortality. The mortality rate was higher in patients with a heart rate >80 bpm (11% vs.
3%; p<0.01).
Conclusions: Higher heart rate 24-36 hours after admission for acute HF is associated
with increased risk of in-hospital mortality. Early targeting of elevated heart rate might
represent a complementary therapeutic challenge.
Variables Whole Cohort Survivors Death p
(n=712) (n=672, 94%) (n=40, 5.6%)
Age, years 72±12 72±12 78±9 0.0021
Male gender, n (%) 425 (60) 396 (59) 29 (73) 0.089
Heart rate, bpm 79±18 78±18 92±22 <0.0001
Systolic BP, mmHg 121±24 122±24 113±30 0.046
Diastolic BP, mmHg 68±13 68±13 58±16 0.0002
LV ejection fraction, % 44±16 44±16 46±15 0.46
Medical history
 Hypertension, n (%) 331 (46) 314 (47) 17 (42) 0.17
 Diabetes, n (%) 132 (17) 118 (17) 14 (35) 0.026
 COPD, n (%) 177 (25) 166 (25) 11 (27) 0.96
 Prior MI, n (%) 129 (18) 125 (19) 4 (10) 0.08
 Prior HF, n (%) 204 (29) 194 (29) 10 (25) 0.28
Laboratory findings
 Hemoglobin, g/L 12±2 12±2 12±2 0.63
 NT-proBNP, pg/mL 9615±12872 8488±10660 24692±26433 0.0005
 Creatinine, mg/dL 14±11 14±10 18.5±18 0.023
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Variables Whole Cohort Survivors Death p
(n=712) (n=672, 94%) (n=40, 5.6%)
 Sodium, mmol/L 140.7±4.4 141±4.2 140±6.3 0.71
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